Biohaven

Biohaven is a clinical-stage biotech developing treatments for immunology, neuroscience, and oncology, targeting neuromuscular and metabolic diseases.
Domain
Healthcare
Status
IPO’d/​Acquired
Acquisition Announcement Date
2022
IPO Date
2017
Stage of Initial Investment
Series A
Initial Investment Year
2016